| http://dbpedia.org/ontology/abstract
|
Koronis Pharmaceuticals is a Seattle area … Koronis Pharmaceuticals is a Seattle area biotechnology company founded in 1998. Koronis is dedicated to the development of antiviral therapeutics based on a novel mechanism, Viral Decay Acceleration (VDA). The Company's lead product candidate is KP-1461 for the treatment of human immunodeficiency virus (HIV) infection. The company also has products in development for the treatment of hepatitis C and RSV infection.reatment of hepatitis C and RSV infection.
|
| http://dbpedia.org/ontology/foundingYear
|
1998
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/KP-1461.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.koronispharma.com +
, https://www.popsci.com/node/205298 +
, https://www.reuters.com/article/us-koronis-hiv-idUSTRE72C1AX20110313 +
, https://www.reuters.com/article/us-koronis-hiv/u-s-hiv-drug-firm-koronis-looks-to-london-listing-idUSTRE72C1AX20110313 +
, https://www.forbes.com/forbes/2011/0808/focus-hiv-biotech-koronis-pandemic-drug-embracing-enemy.html%231afb122d73df +
, https://www.seattlepi.com/business/article/Biotech-pioneer-Gillis-ventures-into-a-new-field-1179674.php +
, https://www.seattlepi.com/news/article/Koronis-HIV-drug-draws-funding-1242160.php +
|
| http://dbpedia.org/ontology/wikiPageID
|
20519274
|
| http://dbpedia.org/ontology/wikiPageLength
|
2824
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1044711698
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Category:Companies_based_in_Seattle +
, http://dbpedia.org/resource/Seattle_P-I +
, http://dbpedia.org/resource/Popular_Science +
, http://dbpedia.org/resource/File:KP-1461.svg +
, http://dbpedia.org/resource/Hepatitis_C +
, http://dbpedia.org/resource/HIV/AIDS +
, http://dbpedia.org/resource/Error_catastrophe +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Reuters +
, http://dbpedia.org/resource/Antiviral_drug +
, http://dbpedia.org/resource/The_New_Yorker +
, http://dbpedia.org/resource/Seattle +
, http://dbpedia.org/resource/KP-1461 +
, http://dbpedia.org/resource/Forbes +
, http://dbpedia.org/resource/Human_respiratory_syncytial_virus +
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Citation +
, http://dbpedia.org/resource/Template:No_footnotes +
, http://dbpedia.org/resource/Template:Start_date_and_age +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Med-company-stub +
, http://dbpedia.org/resource/Template:Refend +
, http://dbpedia.org/resource/Template:Refbegin +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Companies_based_in_Seattle +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Koronis_Pharmaceuticals?oldid=1044711698&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/KP-1461.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Koronis_Pharmaceuticals +
|
| owl:sameAs |
http://rdf.freebase.com/ns/m.051z9jv +
, http://yago-knowledge.org/resource/Koronis_Pharmaceuticals +
, http://www.wikidata.org/entity/Q6432542 +
, https://global.dbpedia.org/id/4pQyi +
, http://dbpedia.org/resource/Koronis_Pharmaceuticals +
|
| rdf:type |
http://dbpedia.org/class/yago/WikicatCompaniesBasedInSeattle%2CWashington +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompaniesOfTheUnitedStates +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://schema.org/Organization +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/ontology/Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/ontology/Company +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
|
| rdfs:comment |
Koronis Pharmaceuticals is a Seattle area … Koronis Pharmaceuticals is a Seattle area biotechnology company founded in 1998. Koronis is dedicated to the development of antiviral therapeutics based on a novel mechanism, Viral Decay Acceleration (VDA). The Company's lead product candidate is KP-1461 for the treatment of human immunodeficiency virus (HIV) infection. The company also has products in development for the treatment of hepatitis C and RSV infection.reatment of hepatitis C and RSV infection.
|
| rdfs:label |
Koronis Pharmaceuticals
|
